Renal sympathetic denervation for the treatment of difficult-to-control or resistant hypertension

International Journal of Hypertension

Volumn 2011, Issue , 2011, Pages

  Papademetriou, Vasilios ^a   Doumas, Michalis ^b   Tsioufis, Konstantinos ^c  

^a GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

^b ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^c UNIVERSITY OF ATHENS   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 1 ADRENERGIC RECEPTOR; BETA 1 ADRENERGIC RECEPTOR; OXYTOCIN; VASOPRESSIN;

ADRENERGIC NERVE; AUTONOMIC DENERVATION; AUTONOMIC INNERVATION; BLOOD PRESSURE REGULATION; CLINICAL EFFECTIVENESS; EFFERENT NERVE; HUMAN; KIDNEY INNERVATION; KIDNEY SYMPATHETIC DENERVATION; KIDNEY TUBULE ABSORPTION; LYMPHATIC SYSTEM DISEASE; MECHANORECEPTOR; NEUROTRANSMITTER RELEASE; ORTHOSTATIC HYPOTENSION; PATIENT SAFETY; PRIORITY JOURNAL; RADIOFREQUENCY ABLATION; RENIN RELEASE; RESISTANT HYPERTENSION; REVIEW; SENSORY NERVE; SEXUAL DYSFUNCTION; SODIUM ABSORPTION; SPLANCHNICECTOMY; SURGICAL APPROACH; SURGICAL TECHNIQUE; SURVIVAL RATE; SYMPATHECTOMY; THORACIC DUCT INJURY;

EID: 80054724312     PISSN: 20900384     EISSN: 20900392     Source Type: Journal    
DOI: 10.4061/2011/196518     Document Type: Review

References (30)

1. Calhoun D. A., Jones D., Textor S., Goff D. C., Murphy T. P., Toto R. D., White A., Cushman W. C., White W., Sica D., Ferdinand K., Giles T. D., Falkner B., Resistant hypertension: siagnosis, evaluation, and treatment a scientific statement from the american heart association professional education committee of the council for high blood pressure research. Hypertension 2008 51 6 1403 1419 10.1161/HYPERTENSIONAHA.108.189141
2. Sarafidis P. A., Bakris G. L., Resistant hypertension. An overview of evaluation and treatment. Journal of the American College of Cardiology 2008 52 22 1749 1757 2-s2.0-56149084750 10.1016/j.jacc.2008.08.036
3. Moser M., Setaro J. F., Resistant or difficult-to-control hypertension. The New England Journal of Medicine 2006 355 4 385 392 2-s2.0-33746430561 10.1056/NEJMcp041698 (Pubitemid 44127541)
4. Wojciechowski D., Papademetriou V., Faselis C., Fletcher R., Evaluation and treatment of resistant or difficult-to-control hypertension. Journal of Clinical Hypertension 2008 10 11 837 843 2-s2.0-60749118941 10.1111/j.1751-7176. 2008.00037.x
5. Veterans Administration Cooperative Study Group on Antihypertensive Agents, Effects of treatment on morbidity in hypertension. Results in patients with diastolic blood pressures averaging 115 through 129 mm Hg. Journal of the American Medical Association 1967 202 11 1028 1034
6. Veterans Administration Cooperative Study Group on Antihypertensive Agents, Effects of treatment on morbidity in hypertension. Results in patients with diastolic blood pressures averaging 90 through 114 mm Hg. Journal of the American Medical Association 1970 202 1143 1152
7. Page I. H., Heuer G. J., A surgical treatment of essential hypertension. The Journal of Clinical Investigation 1935 14 22 26
8. Freyberg R. H., Peet M. M., The effect on the kidney of bilateral splanchnicectomy in patients with hypertension. The Journal of Clinical Investigation 1937 16 49 65
9. Smithwick R. H., Surgical treatment of hypertension. The American Journal of Medicine 1948 4 5 744 759 2-s2.0-3342907322
10. Isberg E. M., Peet M. M., The influence of supradiaphragmatic splanchnicectomy on the heart in hypertension. American Heart Journal 1948 35 4 567 583 2-s2.0-50349141721
11. Allen E. V., Sympathectomy for essential hypertension. Circulation 1952 6 1 131 140 2-s2.0-75349098765
12. Whitelaw G. P., Kinsey D., Smithwick R. H., Factors influencing the choice of treatment in essential hypertension. Surgical, medical or a combination of both. The American Journal of Surgery 1964 107 1 220 231 2-s2.0-50549198677
13. Doumas M., Guo D., Papademetriou V., Carotid baroreceptor stimulation as a therapeutic target in hypertension and other cardiovascular conditions. Expert Opinion on Therapeutic Targets 2009 13 4 413 425 2-s2.0-64049119196 10.1517/14728220902780185
14. Krum H., Schlaich M., Whitbourn R., Sobotka P. A., Sadowski J., Bartus K., Kapelak B., Walton A., Sievert H., Thambar S., Abraham W. T., Esler M., Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study. The Lancet 2009 373 9671 1275 1281 2-s2.0-64049084640 10.1016/S0140-6736(09)60566-3
15. Doumas M., Douma S., Interventional management of resistant hypertension. The Lancet 2009 373 9671 1228 1230 2-s2.0-64049085733 10.1016/S0140-6736(09) 60624-3
16. DiBona G. F., Kopp U. C., Neural control of renal function. Physiological Reviews 1997 77 1 75 197 2-s2.0-0031015981 (Pubitemid 27069290)
17. Kopp U. C., DiBona G. F., Seldin G., Giebisch G., The neural control of renal function. The Kidney: Physiology and Pathophysiology 2006 3rd New York, NY, USA Raven Press 981 1006
18. Barajas L., Liu L., Powers K., Anatomy of the renal innervation: intrarenal aspects and ganglia of origin. Canadian Journal of Physiology and Pharmacology 1992 70 5 735 749 2-s2.0-0026688370
19. Luff S. E., Hengstberger S. G., McLachlan E. M., Anderson W. P., Distribution of sympathetic neuroeffector junctions in the juxtaglomerular region of the rabbit kidney. Journal of the Autonomic Nervous System 1992 40 3 239 254 2-s2.0-0026757504 10.1016/0165-1838(92)90206-V
20. Barajas L., Powers K., Wang P., Innervation of the renal cortical tubules: a quantitative study. American Journal of Physiology 1984 247 1 F50 F60 2-s2.0-0021464588 (Pubitemid 14091528)
21. Esler M., The sympathetic system and hypertension. American Journal of Hypertension 2000 13 6 S99 S105 2-s2.0-0033912454
22. Esler M., Rumantir M., Kaye D., Jennings G., Hastings J., Socratous F., Lambert G., Sympathetic nerve biology in essential hypertension. Clinical and Experimental Pharmacology and Physiology 2001 28 12 986 989 2-s2.0-0035681029 10.1046/j.1440-1681.2001.03566.x (Pubitemid 34053507)
23. 2-mediated stimulation of renal sensory nerves. American Journal of Physiology 2004 287 6 F1269 F1282 2-s2.0-8644228589 10.1152/ajprenal.00230.2004 (Pubitemid 39507236)
24. Kopp U. C., Cicha M. Z., Smith L. A., Hökfelt T., Nitric oxide modulates renal sensory nerve fibers by mechanisms related to substance preceptor activation. American Journal of Physiology 2001 281 1 R279 R290 2-s2.0-0034804116
25. Liu L., Barajas L., The rat renal nerves during development. Anatomy and Embryology 1993 188 4 345 361 2-s2.0-0027423210 (Pubitemid 23305156)
26. Stella A., Zanchetti A., Functional role of renal afferents. Physiological Reviews 1991 71 3 659 682 2-s2.0-0025909806
27. Keith N. M., Wagener H. P., Barker N. W., Some different types of essential hypertension: their course and prognosis. American Journal of the Medical Sciences 1974 268 6 336 345 2-s2.0-0016329387
28. Smithwick R. H., Hypertensive vascular disease. Results of and indications for splanchnicectomy. Journal of Chronic Diseases 1955 1 5 477 496 2-s2.0-50449120007
29. Schlaich M. P., Sobotka P. A., Krum H., Lambert E., Esler M. D., Renal sympathetic-nerve ablation for uncontrolled hypertension. The New England Journal of Medicine 2009 361 9 932 934 2-s2.0-69349085170 10.1056/NEJMc0904179
30. Esler M. D., Krum H., Sobotka P. A., Schlaich M. P., Schmieder R. E., Böhm M., Mahfoud F., Sievert H., Wunderlich N., Rump L. C., Vonend O., Uder M., Lobo M., Caulfield M., Erglis A., Azizi M., Sapoval M., Thambar S., Persu A., Renkin J., Schunkert H., Weil J., Hoppe U. C., Walton T., Scheinert D., Binder T., Januszewicz A., Witkowski A., Ruilope L. M., Whitbourn R., Bruck H., Downes M., Lüscher T. F., Jardine A. G., Webster M. W., Zeller T., Sadowski J., Bartus K., Straley C. A., Barman N. C., Lee D. P., Witteles R. M., Bhalla V., Massaro J. M., Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): a randomised controlled trial. The Lancet 2010 376 9756 1903 1909 10.1016/S0140-6736(10) 62039-9